CRH Medical reports issuance of stock options



    VANCOUVER, Jan. 21 /CNW/ - CRH Medical Corporation (CRM:TSX-V) announced
today that in conjunction with its annual evaluation process it has issued
1,150,000 incentive stock options to four directors and two officers of the
Company exercisable at $0.65 for a period of five years pursuant to its Stock
Option Plan. Additionally, 1,000 options were issued to an officer of the
Company on December 3, 2008, exercisable at $.59 for a period of 5 years. Its
Stock Option Plan has been approved by Shareholders and the TSX Venture
Exchange.

    About CRH Medical Corporation:

    CRH Medical Corporation is utilizing the first single use, patented,
disposable, hemorrhoid banding system through its Center for Colorectal Health
facilities. According to the National Institute of Health approximately 50% of
the U.S. population will develop hemorrhoids by age 50. CRH Medical is opening
its Center for Colorectal Health facilities in the United States specializing
in the treatment of hemorrhoids, anal fissures, and colon cancer screening and
plans to significantly increase the number of Centers for Colorectal Health
across the U.S. to address this underserved market. The Company's goal is to
become the preeminent resource on colorectal health for consumers and medical
professionals in North America.

    The information in this news release contains so-called "forward-looking"
statements. These include statements regarding CRH Medical's expectations and
plans relating to its expansion plans for its Centers for Colorectal Health,
statements about CRH Medical's expectations, beliefs, intentions or strategies
for the future, which may be indicated by words or phrases such as
"anticipate", "expect", "intend", "plan", "will", "we believe", "CRH Medical
believes", "management believes", and similar language. All forward-looking
statements are based on CRH Medical's current expectations and are subject to
risks and uncertainties and to assumptions made. Important factors that could
cause actual results to differ materially from those expressed or implied by
such forward-looking statements include: (i) the company's ability to
successfully recruit medical professionals for its Centers for Colorectal
Health (ii) the company's ability to manufacture its products; (iii)
decisions, and the timing of decisions, made by the health regulatory agencies
regarding the company's products; (iv) the company's ability to enter into
distribution agreements for its products, and to complete and maintain
corporate alliances relating to the development, commercialization and use of
its technology and products; (v) market acceptance of its technologies and
products; and (vi) the competitive environment and impact of technological
change. CRH Medical bases its forward-looking statements on information
currently available to it, and assumes no obligation to update them.

    
    The TSX Venture Exchange does not accept responsibility for the adequacy
    or accuracy of this release.
    





For further information:

For further information: Dean Linden, Corporate Communications, CRH
Medical Corporation at (604) 633-1440 or ir@crhmedcorp.com. Additional
information may also be found by visiting the Company's website at
www.crhmedcorp.com or the SEDAR website at www.sedar.com


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890